Organization
Janssen Pharmaceutica
5 clinical trials
Clinical trial
A Phase 1, Open-label, Parallel-group Study to Assess the Effect of Steady-state Carbamazepine on the Pharmacokinetics of Ponesimod in Healthy Adult ParticipantsStatus: Completed, Estimated PCD: 2023-03-05
Clinical trial
A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Bipolar DepressionStatus: Recruiting, Estimated PCD: 2024-03-22
Clinical trial
An Open-label, Non-randomized Study to Investigate the Effects of Twice-Daily Milvexian Administration on the Pharmacokinetics of Single Doses of Midazolam, Ethinylestradiol and Drospirenone in Healthy Adult FemalesStatus: Completed, Estimated PCD: 2023-07-20
Clinical trial
Assessment of Guselkumab (Tremfya) and IL-17 Inhibitor Therapies in Patients With Psoriatic Arthritis in Routine Clinical Practice; A Prospective, Observational Cohort StudyStatus: Active (not recruiting), Estimated PCD: 2027-12-07
Clinical trial
A Randomized, Controlled, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer, Assessed by PSMA-PET With an Observational CohortStatus: Recruiting, Estimated PCD: 2029-08-27